Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $675.3900 (-2.1%) ($673.9800 - $675.3900) on Tue. Apr. 26, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.51% (three month average) | RSI | 48 | Latest Price | $675.3900(-2.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.2% a day on average for past five trading days. | Weekly Trend | REGN declines -1.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) DIA(40%) IWD(39%) SPY(38%) XLV(38%) | Factors Impacting REGN price | REGN will decline at least -0.755% in a week (0% probabilities). VIXM(-19%) TBT(-13%) UUP(-8%) VXX(-3%) USO(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.755% (StdDev 1.51%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $708.38 | 5 Day Moving Average | $695.73(-2.92%) | 10 Day Moving Average | $708.7(-4.7%) | 20 Day Moving Average | $708.38(-4.66%) | To recent high | -8.6% | To recent low | 12.1% | Market Cap | $71.611b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |